Melanoma, New Pill 'Undo' Advanced Tumor and Slows Growth
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Giornale Radio
"The addition of the innovative HBI-8000 tablet drug to standard nivolumab immunotherapy proves to be a new promising weapon against advanced melanoma: "The addition of the innovative HBI-8000 tablet drug to standard nivolumab immunotherapy proves to be significantly more effective than monotherapy alone: it reduces the risk of disease progressing by 27% and brings progression-free median survival to 11.7 months (compared to 7.4 months obtained …
In collaboration with Il Sole 24 hours we receive and publish the link of the following news. Opinion and thanks the publisher for the multimedia partnership. /// A pill able to strip the tumor to make it more visible to the immune system has turned out to be a new promising weapon against advanced melanoma. The addition of the innovative drug in... Link to the [...]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
